By Michael Erman NEW YORK (Reuters) - Drugmakers Pfizer Inc (NYSE:PFE), Bristol-Myers Squibb (NYSE:BMY) Co and Sanofi (PA:SASY) SA said on Wednesday that their chief executives...
2019 may be a different story.
By Yasmeen Abutaleb WASHINGTON (Reuters) - U.S. Senator Bernie Sanders sent a letter to Catalyst Pharmaceuticals (O:CPRX) on Monday asking it to justify its decision to charge...
Novo Nordisk (CO:NOVOb) A/S (NYSE:NVO) announced that the FDA has approved its biologics license application (BLA) for Esperoct (turoctocog alfa pegol, N8-GP) regarding the...
Seattle Genetics, Inc. (NASDAQ:SGEN) announced that its Japanese partner, Takeda Pharmaceutical Company Limited received approval from the European Commission (EC) to extend the...
Sanofi (PA:SASY) (NASDAQ:SNY) reported fourth-quarter 2018 earnings of 63 cents per American depositary share, which beat the Zacks Consensus Estimate of 61 cents. Earnings...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Strong Sell||Strong Sell||Buy||Buy||Buy|
|Technical Indicators||Strong Sell||Sell||Strong Sell||Strong Buy||Strong Buy|
|Summary||Strong Sell||Strong Sell||Neutral||Strong Buy||Strong Buy|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Three Black Crows||15||Current|
|On Neck Bearish||15||1||Feb 20, 2019 10:30AM|
|Three Outside Up||1W||2||Feb 03, 2019|
|Falling Three Methods||5H||2||Feb 19, 2019 06:00AM|
|CVS Health Corp||64.93||65.13||63.30||-4.94||-7.06%||29.10M||12:01:38|
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.Read More
|U.S. Commodity Futures Trading Commission (United States)||$250||Start Trading|
|U.S. Commodity Futures Trading Commission (United States)||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.